Tonix Pharmaceuticals Holding Corp.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Profit margin reached -1502%. Total operating expenses were $121,407,000.

Profit Margin

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP): Profit margin
2014 0 -27.61M
2015 0 -48.05M
2016 0 -38.84M
2017 0 -21.12M
2018 0 -26.08M
2019 0 -28.38M
2020 0 -52.17M
2021 0 -92.21M
2022 0 -115.00M
2023 7.76M -116.65M -1501.78%

TNXP Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
7.76M000000000
Cost of revenue
4.74M112.09M92.31M50.51M28.82M26.32M21.29M38.96M48.16M27.65M
Gross profit
3.02M-112.09M-92.31M-50.51M-28.82M-26.32M-21.29M-38.96M-48.16M-27.65M
Operating exp.
Research and development
86.65M81.87M68.83M36.15M18.19M17.55M13.34M28.53M35.50M18.61M
Selling and marketing
0000000000
Total operating expenses
121.40M112.09M92.31M50.51M28.82M26.32M21.29M38.96M48.16M27.65M
Operating income
-118.38M-112.09M-92.31M-50.51M-28.82M-26.32M-21.29M-38.96M-48.16M-27.65M
Other income (expenses), net
1.72M1.87M25K48K210K233K168K127K108K40K
Income before tax
-116.65M-110.21M-92.28M-50.46M-28.61M-26.08M-21.12M-38.84M-48.05M-27.61M
Income tax expense
04.78M-75K-75K-236K233K-70K-206K-161K-36K
Net income
-116.65M-115.00M-92.21M-52.17M-28.38M-26.08M-21.12M-38.84M-48.05M-27.61M
Earnings per share
Basic EPS
-219.09-20.11-51.2-3.53K-3.52K-16.05K0-199.18K00
Diluted EPS
-219.09-20.11-51.2-3.53K-3.52K-16.05K0-199.18K00
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source